Skip to main content
logo
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.980
-0.005 (-0.25%)
At close: Sep 2, 2026, 4:00 PM EDT
1.990
+0.010 (0.51%)
Pre-market: Sep 3, 2026, 9:13 AM EDT

Allogene Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6843084475409072,126
Market Cap Growth
172.84%-31.06%-17.32%-40.45%-57.34%-39.95%
Enterprise Value
4301412481714571,697
Last Close Price
1.981.372.133.216.2914.92

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
147.43-20300.075685.985814.6318.64
PB Ratio
1.571.051.061.061.362.32
P/TBV Ratio
1.571.051.061.061.362.32

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
92.78-11252.801803.612931.9914.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.180.280.220.190.150.08
Net Debt / Equity Ratio
-0.58-0.57-0.48-0.69-0.62-0.42
Net Debt / EBITDA Ratio
1.500.860.831.181.302.26
Net Debt / FCF Ratio
2.471.121.001.481.841.86
Asset Turnover
0.01-0000.10
Quick Ratio
10.557.748.2912.159.699.62
Current Ratio
10.727.938.5412.389.849.78
Return on Equity (ROE)
-42.39%-53.42%-55.13%-55.51%-43.00%-18.24%
Return on Assets (ROA)
-22.08%-26.82%-27.01%-26.84%-22.55%-9.94%
Return on Capital Employed (ROCE)
-34.80%-54.00%-50.20%-51.90%-43.70%-18.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-24.19%-62.00%-57.68%-60.59%-37.53%-8.56%
FCF Yield
-15.00%-48.60%-45.01%-44.29%-24.88%-9.70%
Buyback Yield / Dilution
-19.14%-13.25%-24.14%-9.63%-5.39%-12.84%
SEC Filings: 10-K · 10-Q